Skip to main content

NCPA survey: Accreditation requirements hinder pharmacists from offering DME


ALEXANDRIA, Va. A survey of National Community Pharmacists Association members found that almost one-third (31%) of independent pharmacist-owners in the DMEPOS business would cease offering durable medical equipment, prosthetics, orthotics and supplies to their Medicare patients if new accreditation mandates take effect on Oct. 1.

That includes diabetes supplies.

“Pharmacists have been unfairly singled out for this accreditation rule, but patients will be the ones who truly lose out if this isn’t changed,” stated Bruce Roberts, NCPA EVP and CEO. “These findings illustrate that the current policy could prevent patients, especially in underserved areas, from accessing medical supplies that help navigate health challenges, such as controlling diabetes. We hope Congress will act swiftly with the accreditation deadline fast approaching.”

For those independents currently not in the DMEPOS business, mandated accreditation would significantly deter 67% of those respondents from participating in the future.

Currently, only 1-in-10 community pharmacies currently providing DMEPOS have become accredited. The accreditation fees, training and implementation costs are projected to total at least $5,000 to $7,000, over three years, which is cost prohibitive for many pharmacists.

This ad will auto-close in 10 seconds